Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)

被引：0
|
作者：
Harding, James J.
Catalanotti, Federica
Yaqubie, Amin
McDermott, Gregory C.
Kersellius, Romona
Merghoub, Taha
Carvajal, Richard D.
D'Angelo, Sandra P.
Dickson, Mark Andrew
Schwartz, Gary K.
Wolchok, Jedd D.
Berger, Michael F.
Solit, David B.
Chapman, Paul B.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] New York Presbyterian Hosp, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9060
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases
    Harding, James J.
    Catalanotti, Federica
    Munhoz, Rodrigo R.
    Cheng, Donavan T.
    Yaqubie, Amin
    Kelly, Nicole
    Mcdermott, Gregory C.
    Kersellius, Romona
    Merghoub, Taha
    Lacouture, Mario E.
    Carvajal, Richard D.
    Panageas, Katherine S.
    Berger, Michael F.
    Rosen, Neal
    Solit, David B.
    Chapman, Paul B.
    [J]. ONCOLOGIST, 2015, 20 (07): : 789 - 797
  • [2] A phase II study evaluating atezolizumab (A), cobimetinib (C), and vemurafenib (V) in patients (pts) with BRAF-mutant melanoma and central nervous system (CNS) metastases (mets).
    Queirolo, Paola
    de la Cruz Merino, Luis
    Abajo Guijarro, Ana Maria
    Tawbi, Hussein Abdul-Hassan
    Dummer, Reinhard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] VemurafenibResistance to vemurafenib in BRAF-mutant metastatic melanoma: case report
    [J]. Reactions Weekly, 2015, 1533 (1) : 437 - 437
  • [4] Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies
    Jang, S.
    Atkins, M. B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (01) : 24 - 31
  • [5] Efficacy and tolerability of vemurafenib in BRAF-mutant acral and mucosal melanoma.
    Bai, Xue
    Si, Lu
    Chi, Zhihong
    Sheng, Xinan
    Cui, Chuanliang
    Kong, Yan
    Dai, Jie
    Mao, Li Li
    Wang, Xuan
    Li, Si Ming
    Tang, Bixia
    Lian, Bin
    Zhou, Li
    Yan, Xieqiao
    Guo, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] CLINICAL CHARACTERISTICS AND SURVIVAL OF BRAF-MUTANT METASTATIC MELANOMA PATIENTS (pts) TREATED WITH THE BRAF INHIBITORS (BRAFi) DABRAFENIB OR VEMURAFENIB BEYOND DISEASE PROGRESSION (PD)
    Chan, M.
    Haydu, L.
    Menzies, A. M.
    Azer, M.
    Klein, O.
    Lyle, M.
    Clements, A.
    Guminski, A.
    Kefford, R.
    Long, G.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 42 - 42
  • [7] Clinical characteristics and survival of BRAF-mutant (BRAF plus ) metastatic melanoma patients (pts) treated with BRAF inhibitor (BRAFi) dabrafenib or vemurafenib beyond disease progression (PD)
    Chan, Matthew
    Haydu, Lauren
    Menzies, Alexander M.
    Azer, Mary W. F.
    Klein, Oliver
    Guminski, Alexander
    Kefford, Richard
    Long, Georgina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Phase I trial evaluating concurrent vemurafenib and ipilimumab in patients with advanced BRAF-mutant melanoma
    Ribas, A.
    Hodi, F. S.
    Callahan, M.
    Chmielowski, B.
    Lawrence, D.
    Konto, C.
    McHenry, M. B.
    Choong, N.
    Wolchok, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S867 - S867
  • [9] Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma
    Touat, Mehdi
    Gratieux, Julie
    Auliac, Stephanie Condette
    Sejean, Karine
    Aldea, Sorin
    Savatovsky, Julien
    Perkins, Geraldine
    Blons, Helene
    Ligon, Keith L.
    Idbaih, Ahmed
    Hollebecque, Antoine
    Gimenez-Roqueplo, Anne-Paule
    Laurent-Puig, Pierre
    Sanson, Marc
    Villa, Chiara
    Di Stefano, Anna Luisa
    [J]. NEUROLOGY, 2018, 91 (11) : 523 - 525
  • [10] Phase I study of combination vemurafenib, carboplatin, and paclitaxel in patients ( pts) with BRAF-mutant advanced cancer
    Kato, Shumei
    Janku, Filip
    Piha-Paul, Sarina Anne
    Naing, Aung
    Karp, Daniel D.
    Tsimberidou, Apostolia Maria
    Subbiah, Vivek
    Zinner, Ralph
    Hwu, Wen-Jen
    Javle, Milind M.
    Parkhurst, Kristin L.
    Ramzanali, Nishma M.
    Kurzrock, Razelle
    Meric-Bernstam, Funda
    Chae, Young Kwang
    Kim, Kevin
    Falchook, Gerald Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345